Am I eligible for this study? If you are over the age of 18, have recurrent adult-type granulosa cell tumors of the ovary, and have had prior treatment, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take […]
Read MoreAbout This Study NRG-GY033 is a clinical trial for patients with adult-type granulosa cell tumors of the ovary. This trial is being done to determine if the combination of the drugs darolutamide, leuprolide acetate, and exemestane are helpful in treating your type of cancer. Though treatment on the trial could possibly shrink your cancer, it […]
Read MoreClinical Studies FAQ
Read MoreThe NRG-GY033 Study FAQ
Read More